http://142-54-23-223.fusionmedialtd.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 17 Jul 2026 19:50:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://142-54-23-223.fusionmedialtd.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Zeiller+Robert+Harold/26785460.html si-local-file:///var/storage/secattach/20260717/26785460.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Zeiller+Robert+Harold/26785460.html Fri, 17 Jul 2026 19:50:00 -0400 GMRE O.14364203 XRN http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Zeiller+Robert+Harold/26785460.html si-local-file:///var/storage/secattach/20260717/26785460.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Zeiller+Robert+Harold/26785460.html Fri, 17 Jul 2026 19:50:00 -0400 GMRE O.14364203 XRN http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Zeiller+Robert+Harold/26785460.html si-local-file:///var/storage/secattach/20260717/26785460.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Zeiller+Robert+Harold/26785460.html Fri, 17 Jul 2026 19:50:00 -0400 GMRE O.14364203 XRN http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Zeiller+Robert+Harold/26785458.html si-local-file:///var/storage/secattach/20260717/26785458.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Zeiller+Robert+Harold/26785458.html Fri, 17 Jul 2026 19:47:00 -0400 GMRE O.14364203 XRN http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Zeiller+Robert+Harold/26785458.html si-local-file:///var/storage/secattach/20260717/26785458.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Zeiller+Robert+Harold/26785458.html Fri, 17 Jul 2026 19:47:00 -0400 GMRE O.14364203 XRN http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Zeiller+Robert+Harold/26785458.html si-local-file:///var/storage/secattach/20260717/26785458.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Zeiller+Robert+Harold/26785458.html Fri, 17 Jul 2026 19:47:00 -0400 GMRE O.14364203 XRN http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Roseth+Aaron+Robert/26785457.html si-local-file:///var/storage/secattach/20260717/26785457.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Roseth+Aaron+Robert/26785457.html Fri, 17 Jul 2026 19:45:00 -0400 GMRE O.14364203 XRN http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Roseth+Aaron+Robert/26785457.html si-local-file:///var/storage/secattach/20260717/26785457.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Roseth+Aaron+Robert/26785457.html Fri, 17 Jul 2026 19:45:00 -0400 GMRE O.14364203 XRN http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Roseth+Aaron+Robert/26785457.html si-local-file:///var/storage/secattach/20260717/26785457.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Chiron+Real+Estate+Inc.+++For%3A+Jul+16++Filed+by%3A+Roseth+Aaron+Robert/26785457.html Fri, 17 Jul 2026 19:45:00 -0400 GMRE O.14364203 XRN http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Chiron+Real+Estate+Inc.+++For%3A+May+29++Filed+by%3A+Fitzgerald+Charles/26593499.html si-local-file:///var/storage/secattach/20260602/26593499.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Chiron+Real+Estate+Inc.+++For%3A+May+29++Filed+by%3A+Fitzgerald+Charles/26593499.html Tue, 02 Jun 2026 17:46:00 -0400 GMRE O.14364203 XRN http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Chiron+Real+Estate+Inc.+++For%3A+May+29++Filed+by%3A+Fitzgerald+Charles/26593499.html si-local-file:///var/storage/secattach/20260602/26593499.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Chiron+Real+Estate+Inc.+++For%3A+May+29++Filed+by%3A+Fitzgerald+Charles/26593499.html Tue, 02 Jun 2026 17:46:00 -0400 GMRE O.14364203 XRN http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Chiron+Real+Estate+Inc.+++For%3A+May+29++Filed+by%3A+Fitzgerald+Charles/26593499.html si-local-file:///var/storage/secattach/20260602/26593499.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Chiron+Real+Estate+Inc.+++For%3A+May+29++Filed+by%3A+Fitzgerald+Charles/26593499.html Tue, 02 Jun 2026 17:46:00 -0400 GMRE O.14364203 XRN http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html <p>Aditxt Inc. (NASDAQ: ADTX) appointed Jeffrey M. Busch as interim chief executive officer, effective May 31, 2026, according to a company statement. Busch has served as CEO of Aditxt's precision oncology diagnostics subsidiary Ignite Proteomics since March 2026 and will continue in that role while leading the parent company.</p> <p>The appointment follows the resignation of co-founder and former CEO Amro Albanna, who stepped down from his position and the company's board. Albanna led Aditxt through its public listing and acquisition strategy, including the addition of Ignite to the company's portfolio.</p> <p>Busch founded Global Medical REIT Inc., which was later renamed Chiron Real http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html Mon, 01 Jun 2026 08:15:18 -0400 A.02927364 A.14320728 A.19718279 A.20922990 A.29114199 A.29393384 A.50213909 ADTX GMRE O.00048977 O.01951358 O.03285274 O.03960701 O.14364203 O.20113531 O.20250741 O.20357061 O.46978405 XRN http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html <p>Aditxt Inc. (NASDAQ: ADTX) appointed Jeffrey M. Busch as interim chief executive officer, effective May 31, 2026, according to a company statement. Busch has served as CEO of Aditxt's precision oncology diagnostics subsidiary Ignite Proteomics since March 2026 and will continue in that role while leading the parent company.</p> <p>The appointment follows the resignation of co-founder and former CEO Amro Albanna, who stepped down from his position and the company's board. Albanna led Aditxt through its public listing and acquisition strategy, including the addition of Ignite to the company's portfolio.</p> <p>Busch founded Global Medical REIT Inc., which was later renamed Chiron Real http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html Mon, 01 Jun 2026 08:15:18 -0400 A.02927364 A.14320728 A.19718279 A.20922990 A.29114199 A.29393384 A.50213909 ADTX GMRE O.00048977 O.01951358 O.03285274 O.03960701 O.14364203 O.20113531 O.20250741 O.20357061 O.46978405 XRN http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html <p>Aditxt Inc. (NASDAQ: ADTX) appointed Jeffrey M. Busch as interim chief executive officer, effective May 31, 2026, according to a company statement. Busch has served as CEO of Aditxt's precision oncology diagnostics subsidiary Ignite Proteomics since March 2026 and will continue in that role while leading the parent company.</p> <p>The appointment follows the resignation of co-founder and former CEO Amro Albanna, who stepped down from his position and the company's board. Albanna led Aditxt through its public listing and acquisition strategy, including the addition of Ignite to the company's portfolio.</p> <p>Busch founded Global Medical REIT Inc., which was later renamed Chiron Real http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html Mon, 01 Jun 2026 08:15:18 -0400 A.02927364 A.14320728 A.19718279 A.20922990 A.29114199 A.29393384 A.50213909 ADTX GMRE O.00048977 O.01951358 O.03285274 O.03960701 O.14364203 O.20113531 O.20250741 O.20357061 O.46978405 XRN http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html <p>Aditxt Inc. (NASDAQ: ADTX) appointed Jeffrey M. Busch as interim chief executive officer, effective May 31, 2026, according to a company statement. Busch has served as CEO of Aditxt's precision oncology diagnostics subsidiary Ignite Proteomics since March 2026 and will continue in that role while leading the parent company.</p> <p>The appointment follows the resignation of co-founder and former CEO Amro Albanna, who stepped down from his position and the company's board. Albanna led Aditxt through its public listing and acquisition strategy, including the addition of Ignite to the company's portfolio.</p> <p>Busch founded Global Medical REIT Inc., which was later renamed Chiron Real http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html Mon, 01 Jun 2026 08:15:18 -0400 A.02927364 A.14320728 A.19718279 A.20922990 A.29114199 A.29393384 A.50213909 ADTX GMRE O.00048977 O.01951358 O.03285274 O.03960701 O.14364203 O.20113531 O.20250741 O.20357061 O.46978405 XRN http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html <p>Aditxt Inc. (NASDAQ: ADTX) appointed Jeffrey M. Busch as interim chief executive officer, effective May 31, 2026, according to a company statement. Busch has served as CEO of Aditxt's precision oncology diagnostics subsidiary Ignite Proteomics since March 2026 and will continue in that role while leading the parent company.</p> <p>The appointment follows the resignation of co-founder and former CEO Amro Albanna, who stepped down from his position and the company's board. Albanna led Aditxt through its public listing and acquisition strategy, including the addition of Ignite to the company's portfolio.</p> <p>Busch founded Global Medical REIT Inc., which was later renamed Chiron Real http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html Mon, 01 Jun 2026 08:15:18 -0400 A.02927364 A.14320728 A.19718279 A.20922990 A.29114199 A.29393384 A.50213909 ADTX GMRE O.00048977 O.01951358 O.03285274 O.03960701 O.14364203 O.20113531 O.20250741 O.20357061 O.46978405 XRN http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html <p>Aditxt Inc. (NASDAQ: ADTX) appointed Jeffrey M. Busch as interim chief executive officer, effective May 31, 2026, according to a company statement. Busch has served as CEO of Aditxt's precision oncology diagnostics subsidiary Ignite Proteomics since March 2026 and will continue in that role while leading the parent company.</p> <p>The appointment follows the resignation of co-founder and former CEO Amro Albanna, who stepped down from his position and the company's board. Albanna led Aditxt through its public listing and acquisition strategy, including the addition of Ignite to the company's portfolio.</p> <p>Busch founded Global Medical REIT Inc., which was later renamed Chiron Real http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html Mon, 01 Jun 2026 08:15:18 -0400 A.02927364 A.14320728 A.19718279 A.20922990 A.29114199 A.29393384 A.50213909 ADTX GMRE O.00048977 O.01951358 O.03285274 O.03960701 O.14364203 O.20113531 O.20250741 O.20357061 O.46978405 XRN http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html <p>Aditxt Inc. (NASDAQ: ADTX) appointed Jeffrey M. Busch as interim chief executive officer, effective May 31, 2026, according to a company statement. Busch has served as CEO of Aditxt's precision oncology diagnostics subsidiary Ignite Proteomics since March 2026 and will continue in that role while leading the parent company.</p> <p>The appointment follows the resignation of co-founder and former CEO Amro Albanna, who stepped down from his position and the company's board. Albanna led Aditxt through its public listing and acquisition strategy, including the addition of Ignite to the company's portfolio.</p> <p>Busch founded Global Medical REIT Inc., which was later renamed Chiron Real http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html Mon, 01 Jun 2026 08:15:18 -0400 A.02927364 A.14320728 A.19718279 A.20922990 A.29114199 A.29393384 A.50213909 ADTX GMRE O.00048977 O.01951358 O.03285274 O.03960701 O.14364203 O.20113531 O.20250741 O.20357061 O.46978405 XRN http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html <p>Aditxt Inc. (NASDAQ: ADTX) appointed Jeffrey M. Busch as interim chief executive officer, effective May 31, 2026, according to a company statement. Busch has served as CEO of Aditxt's precision oncology diagnostics subsidiary Ignite Proteomics since March 2026 and will continue in that role while leading the parent company.</p> <p>The appointment follows the resignation of co-founder and former CEO Amro Albanna, who stepped down from his position and the company's board. Albanna led Aditxt through its public listing and acquisition strategy, including the addition of Ignite to the company's portfolio.</p> <p>Busch founded Global Medical REIT Inc., which was later renamed Chiron Real http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html Mon, 01 Jun 2026 08:15:18 -0400 A.02927364 A.14320728 A.19718279 A.20922990 A.29114199 A.29393384 A.50213909 ADTX GMRE O.00048977 O.01951358 O.03285274 O.03960701 O.14364203 O.20113531 O.20250741 O.20357061 O.46978405 XRN http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html <p>Aditxt Inc. (NASDAQ: ADTX) appointed Jeffrey M. Busch as interim chief executive officer, effective May 31, 2026, according to a company statement. Busch has served as CEO of Aditxt's precision oncology diagnostics subsidiary Ignite Proteomics since March 2026 and will continue in that role while leading the parent company.</p> <p>The appointment follows the resignation of co-founder and former CEO Amro Albanna, who stepped down from his position and the company's board. Albanna led Aditxt through its public listing and acquisition strategy, including the addition of Ignite to the company's portfolio.</p> <p>Busch founded Global Medical REIT Inc., which was later renamed Chiron Real http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html Mon, 01 Jun 2026 08:15:18 -0400 A.02927364 A.14320728 A.19718279 A.20922990 A.29114199 A.29393384 A.50213909 ADTX GMRE O.00048977 O.01951358 O.03285274 O.03960701 O.14364203 O.20113531 O.20250741 O.20357061 O.46978405 XRN http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html <p>Aditxt Inc. (NASDAQ: ADTX) appointed Jeffrey M. Busch as interim chief executive officer, effective May 31, 2026, according to a company statement. Busch has served as CEO of Aditxt's precision oncology diagnostics subsidiary Ignite Proteomics since March 2026 and will continue in that role while leading the parent company.</p> <p>The appointment follows the resignation of co-founder and former CEO Amro Albanna, who stepped down from his position and the company's board. Albanna led Aditxt through its public listing and acquisition strategy, including the addition of Ignite to the company's portfolio.</p> <p>Busch founded Global Medical REIT Inc., which was later renamed Chiron Real http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html Mon, 01 Jun 2026 08:15:18 -0400 A.02927364 A.14320728 A.19718279 A.20922990 A.29114199 A.29393384 A.50213909 ADTX GMRE O.00048977 O.01951358 O.03285274 O.03960701 O.14364203 O.20113531 O.20250741 O.20357061 O.46978405 XRN http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html <p>Aditxt Inc. (NASDAQ: ADTX) appointed Jeffrey M. Busch as interim chief executive officer, effective May 31, 2026, according to a company statement. Busch has served as CEO of Aditxt's precision oncology diagnostics subsidiary Ignite Proteomics since March 2026 and will continue in that role while leading the parent company.</p> <p>The appointment follows the resignation of co-founder and former CEO Amro Albanna, who stepped down from his position and the company's board. Albanna led Aditxt through its public listing and acquisition strategy, including the addition of Ignite to the company's portfolio.</p> <p>Busch founded Global Medical REIT Inc., which was later renamed Chiron Real http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html Mon, 01 Jun 2026 08:15:18 -0400 A.02927364 A.14320728 A.19718279 A.20922990 A.29114199 A.29393384 A.50213909 ADTX GMRE O.00048977 O.01951358 O.03285274 O.03960701 O.14364203 O.20113531 O.20250741 O.20357061 O.46978405 XRN http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html <p>Aditxt Inc. (NASDAQ: ADTX) appointed Jeffrey M. Busch as interim chief executive officer, effective May 31, 2026, according to a company statement. Busch has served as CEO of Aditxt's precision oncology diagnostics subsidiary Ignite Proteomics since March 2026 and will continue in that role while leading the parent company.</p> <p>The appointment follows the resignation of co-founder and former CEO Amro Albanna, who stepped down from his position and the company's board. Albanna led Aditxt through its public listing and acquisition strategy, including the addition of Ignite to the company's portfolio.</p> <p>Busch founded Global Medical REIT Inc., which was later renamed Chiron Real http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html Mon, 01 Jun 2026 08:15:18 -0400 A.02927364 A.14320728 A.19718279 A.20922990 A.29114199 A.29393384 A.50213909 ADTX GMRE O.00048977 O.01951358 O.03285274 O.03960701 O.14364203 O.20113531 O.20250741 O.20357061 O.46978405 XRN http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html <p>Aditxt Inc. (NASDAQ: ADTX) appointed Jeffrey M. Busch as interim chief executive officer, effective May 31, 2026, according to a company statement. Busch has served as CEO of Aditxt's precision oncology diagnostics subsidiary Ignite Proteomics since March 2026 and will continue in that role while leading the parent company.</p> <p>The appointment follows the resignation of co-founder and former CEO Amro Albanna, who stepped down from his position and the company's board. Albanna led Aditxt through its public listing and acquisition strategy, including the addition of Ignite to the company's portfolio.</p> <p>Busch founded Global Medical REIT Inc., which was later renamed Chiron Real http://www.streetinsider.com/Management+Changes/Aditxt+names+Jeffrey+Busch+as+interim+CEO/26579715.html Mon, 01 Jun 2026 08:15:18 -0400 A.02927364 A.14320728 A.19718279 A.20922990 A.29114199 A.29393384 A.50213909 ADTX GMRE O.00048977 O.01951358 O.03285274 O.03960701 O.14364203 O.20113531 O.20250741 O.20357061 O.46978405 XRN